Number of items: 4.
Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease. (2026)
Alessia Favaron,
Nannapat Sangfuang,
Laura E. McCoubrey,
Atheer Awad,
Jonas Ghyselinck,
Massimo Marzorati,
Lynn Verstrepen,
Julie De Munck,
Jelle De Medts,
Abdul W. Basit
and
Mine Orlu
Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn's disease: A pilot study. (2025)
Nannapat Sangfuang,
Laura E. McCoubrey,
Atheer Awad,
Massimo Marzorati,
Jonas Ghyselinck,
Lynn Verstrepen,
Julie De Munck,
Jelle De Medts,
Simon Gaisford
and
Abdul W. Basit
Dual action tofacitinib-loaded PLGA nanoparticles alleviate colitis in an IBD mouse model. (2024)
Nidhi Seegobin,
Laura E. McCoubrey,
Cécile Vignal,
Christophe Waxin,
Youssef Abdalla,
Yue Fan,
Atheer Awad,
Sudaxshina Murdan
and
Abdul W. Basit
Poly(D,l-lactide-co-glycolide) particles are metabolised by the gut microbiome and elevate short chain fatty acids. (2024)
Laura E. McCoubrey,
Fabiana Ferraro,
Nidhi Seegobin,
Jérémy Verin,
Haya A. Alfassam,
Atheer Awad,
Massimo Marzorati,
Lynn Verstrepen,
Jonas Ghyselinck,
Julie De Munck,
Jelle De Medts,
Evi Steppe,
Valerie De Vleeschhauwer,
Gilles De Rocker,
Alexandra Droesbeke,
Melanie De Rijck,
Sara Vanthoor,
Frédéric Moens,
Juergen Siepmann,
Florence Siepmann,
Simon Gaisford,
Mine Orlu
and
Abdul W. Basit
This list was generated on Thu Jun 18 01:41:43 2026 BST.